Taichun Qin

FDA investigator · also recorded as Oe Nvu Taichun Qin

Appears on 35 documents from 2017 to 2025, most often at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113).

35
Documents on file
5.7
Observations per 483
2017
First seen
2025
Most recent

What they cite most

From 191 observations

Activity by year

2017: 1, 2018: 3, 2019: 4, 2020: 3, 2021: 5, 2022: 5, 2023: 2, 2024: 5, 2025: 7

Where

California 13 · India 3 · Canada 2 · Colorado 2 · France 2 · Nevada 2

Is Taichun Qin coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

35 documents, newest first
FirmOpen
483 ProRx LLCSep 19, 2025 · Exton, Pennsylvania
483 ProRx LLCSep 9, 2025 · Exton, Pennsylvania
483 AnazaoHealth CorporationAug 8, 2025 · Las Vegas, Nevada
483 Stokes Healthcare Inc. dba Epicur PharmaMay 23, 2025 · Mount Laurel, New Jersey
483 Thrive Health and Wellness, LLC, dba Th.rive Health SolutionsApr 3, 2025 · En, Colorado
483 PALMETTO ISOTOPES, LLCFeb 28, 2025 · Ridgeland, South Carolina
483 Carolina InfusionJan 24, 2025 · Ridgeland, South Carolina

About this profile

What does Taichun Qin inspect?

Taichun Qin appears on 35 documents on file covering 33 sites, most often in California.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by FDCA 501(a)(2)(A) and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Taichun Qin is dated Sep 19, 2025.